Skip to main content
Premium Trial:

Request an Annual Quote

Vela Diagnostics Coronavirus RT-PCR Test Provisionally Authorized by Singapore Regulator

NEW YORK – Vela Diagnostics said on Thursday it has received provisional authorization from Singapore's Health Sciences Authority for the firm's ViroKey SARS-CoV-2 RT-PCR Test.

As a result, Vela can offer the test to healthcare institutes, private hospitals, medical clinics, and clinical laboratories licensed in Singapore.

The test is a probe-based reverse transcription PCR test for detecting the coronavirus by targeting conserved regions of its genome, the firm said, adding the manual version of the assay can be adopted by laboratories equipped with Thermo Fisher Scientific's Applied Biosystems 7500 Fast Dx platforms. Vela has also developed a research-use-only automated version of the test for high-throughput testing. The RUO assay is optimized for use with the Sentosa SX101 instrument, Sentosa SA201 instrument, and Applied Biosytems 7500 Fast Dx.

The test is awaiting CE marking, Vela said.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.